FierceBiotech ١٦ يناير ٢٠٢٦ JPM26: Chugai chases new science and name recognition from US biopharma industry
FierceBiotech ١٥ يناير ٢٠٢٦ Boston Scientific to snap up thrombectomy specialist Penumbra in deal valued at $14.5B
FierceBiotech ١٥ يناير ٢٠٢٦ Ocugen posts midphase gene therapy data, charting course for rivalry with Apellis, Astellas
FierceBiotech ١٥ يناير ٢٠٢٦ Novo Nordisk Foundation invests $860M in Danish institute nurturing homegrown biotechs
FierceBiotech ١٥ يناير ٢٠٢٦ Italy's Alfasigma pens €125M deal for injectable form of German biotech's HSV treatment
FierceBiotech ١٥ يناير ٢٠٢٦ JPM26: With pricing deal in the books, Sanofi steels against lingering policy unknowns
FierceBiotech ١٤ يناير ٢٠٢٦ JPM26: Leo Pharma, hungry for more partnerships, looks to widen reach in rare dermatology diseases
FierceBiotech ١٤ يناير ٢٠٢٦ JPM26: Illumina working with China on 'a path through' its export troubles, sees academic research environment 'muted' for '26
FierceBiotech ١٤ يناير ٢٠٢٦ JPM26: As lenacapavir momentum builds, Gilead eyes new deals from a 'position of strength'
FierceBiotech ١٣ يناير ٢٠٢٦ Saga Diagnostics expands ultrasensitive blood test to include colorectal cancer
FierceBiotech ١٣ يناير ٢٠٢٦ JPM26, Day 2: Amgen touts MariTide's showing in exploratory weight loss maintenance study
FierceBiotech ١٣ يناير ٢٠٢٦ Labcorp adds to its suite of tests to speed up detection of the recurrence of a range of common cancers